Krensavage Asset Management, LLC United Therapeutics Corp Transaction History

Krensavage Asset Management, LLC

  • $178 Million
  • Q3 2024

A detailed history of Krensavage Asset Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Krensavage Asset Management, LLC holds 100,332 shares of UTHR stock, worth $36.5 Million. This represents 20.15% of its overall portfolio holdings.

Number of Shares
100,332
Previous 118,208 15.12%
Holding current value
$36.5 Million
Previous $37.7 Million 4.52%
% of portfolio
20.15%
Previous 17.29%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$311.04 - $363.55 $5.56 Million - $6.5 Million
-17,876 Reduced 15.12%
100,332 $36 Million
Q2 2024

Aug 14, 2024
SELL
$228.26 - $319.04 $8.79 Million - $12.3 Million
-38,506 Reduced 24.57%
118,208 $37.7 Million
Q1 2024

May 15, 2024
SELL
$210.76 - $249.51 $9.31 Million - $11 Million
-44,158 Reduced 21.98%
156,714 $36 Million
Q4 2023

Feb 14, 2024
SELL
$214.88 - $256.94 $75,208 - $89,929
-350 Reduced 0.17%
200,872 $44.2 Million
Q3 2023

Nov 14, 2023
SELL
$211.82 - $248.24 $316,247 - $370,622
-1,493 Reduced 0.74%
201,222 $45.5 Million
Q2 2023

Aug 11, 2023
BUY
$205.19 - $232.99 $124,139 - $140,958
605 Added 0.3%
202,715 $44.7 Million
Q1 2023

May 15, 2023
BUY
$212.99 - $276.17 $2.14 Million - $2.78 Million
10,062 Added 5.24%
202,110 $45.3 Million
Q4 2022

Feb 15, 2023
SELL
$205.95 - $280.43 $1.72 Million - $2.34 Million
-8,359 Reduced 4.17%
192,048 $53.4 Million
Q3 2022

Nov 14, 2022
SELL
$203.3 - $244.17 $166,909 - $200,463
-821 Reduced 0.41%
200,407 $42 Million
Q2 2022

Aug 16, 2022
SELL
$174.81 - $241.14 $67,127 - $92,597
-384 Reduced 0.19%
201,228 $47.4 Million
Q1 2022

May 17, 2022
SELL
$166.16 - $213.96 $531,712 - $684,672
-3,200 Reduced 1.56%
201,612 $36.2 Million
Q4 2021

Feb 15, 2022
SELL
$184.32 - $216.08 $456,192 - $534,798
-2,475 Reduced 1.19%
204,812 $44.3 Million
Q3 2021

Nov 16, 2021
SELL
$179.86 - $214.88 $2.23 Million - $2.67 Million
-12,403 Reduced 5.65%
207,287 $38.3 Million
Q2 2021

Aug 13, 2021
SELL
$170.47 - $211.93 $5.07 Million - $6.3 Million
-29,731 Reduced 11.92%
219,690 $39.4 Million
Q1 2021

May 18, 2021
SELL
$153.94 - $174.85 $11.3 Million - $12.8 Million
-73,116 Reduced 22.67%
249,421 $41.7 Million
Q4 2020

Feb 17, 2021
SELL
$101.87 - $151.79 $10.6 Million - $15.7 Million
-103,678 Reduced 24.33%
322,537 $49 Million
Q3 2020

Dec 08, 2020
BUY
$99.9 - $121.13 $38.3 Million - $46.4 Million
383,167 Added 890.09%
426,215 $43 Million
Q3 2020

Nov 17, 2020
SELL
$99.9 - $121.13 $42.9 Million - $52 Million
-429,500 Reduced 90.89%
43,048 $43 Million
Q2 2020

Aug 17, 2020
SELL
$92.74 - $125.82 $6.22 Million - $8.44 Million
-67,098 Reduced 12.43%
472,548 $57.2 Million
Q1 2020

May 18, 2020
BUY
$79.39 - $115.35 $6.25 Million - $9.08 Million
78,702 Added 17.07%
539,646 $51.2 Million
Q4 2019

Feb 18, 2020
SELL
$78.31 - $95.34 $6.2 Million - $7.55 Million
-79,150 Reduced 14.65%
460,944 $40.6 Million
Q3 2019

Nov 15, 2019
SELL
$74.85 - $85.99 $763,844 - $877,527
-10,205 Reduced 1.85%
540,094 $43.1 Million
Q2 2019

Aug 14, 2019
BUY
$76.06 - $120.81 $3.42 Million - $5.44 Million
45,000 Added 8.91%
550,299 $43 Million
Q1 2019

May 15, 2019
BUY
$107.15 - $126.84 $1.46 Million - $1.73 Million
13,606 Added 2.77%
505,299 $59.3 Million
Q4 2018

Feb 15, 2019
SELL
$101.4 - $128.73 $98,053 - $124,481
-967 Reduced 0.2%
491,693 $53.5 Million
Q4 2018

Feb 14, 2019
BUY
$101.4 - $128.73 $664,879 - $844,082
6,557 Added 1.35%
492,660 $57.1 Million
Q3 2018

Nov 14, 2018
SELL
$113.81 - $129.46 $7.5 Million - $8.53 Million
-65,916 Reduced 11.94%
486,103 $62.2 Million
Q2 2018

Aug 13, 2018
SELL
$101.14 - $118.31 $10.3 Million - $12 Million
-101,768 Reduced 15.57%
552,019 $62.5 Million
Q1 2018

May 14, 2018
BUY
$107.21 - $151.94 $38.5 Million - $54.6 Million
359,358 Added 122.05%
653,787 $73.5 Million
Q4 2017

Feb 14, 2018
SELL
$118.58 - $151.28 $6.18 Million - $7.88 Million
-52,082 Reduced 15.03%
294,429 $43.6 Million
Q3 2017

Nov 14, 2017
BUY
$114.6 - $136.81 $39.7 Million - $47.4 Million
346,511
346,511 $40.6 Million

Others Institutions Holding UTHR

# of Institutions
671
Shares Held
42.3M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Krensavage Asset Management, LLC Portfolio

Follow Krensavage Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krensavage Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krensavage Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email